Cargando…

WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel

WT1 is a transcription factor which regulates the epithelial-mesenchymal balance during embryonic development and, if mutated, can lead to the formation of Wilms’ tumour, the most common paediatric kidney cancer. Its expression has also been reported in several adult tumour types, including breast c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Artibani, Mara, Sims, Andrew H., Slight, Joan, Aitken, Stuart, Thornburn, Anna, Muir, Morwenna, Brunton, Valerie G., Del-Pozo, Jorge, Morrison, Linda R., Katz, Elad, Hastie, Nicholas D., Hohenstein, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366898/ https://www.ncbi.nlm.nih.gov/pubmed/28345629 http://dx.doi.org/10.1038/srep45255

Ejemplares similares

Transcription factor Wilms’ tumor 1 regulates developmental RNAs through 3′ UTR interaction
por: Bharathavikru, Ruthrothaselvi, et al.
Publicado: (2017)

WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer
por: McGregor, Richard J., et al.
Publicado: (2018)

A Universal Vector for High-Efficiency Multi-Fragment Recombineering of BACs and Knock-In Constructs
por: Dolt, Karamjit Singh, et al.
Publicado: (2013)

Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice
por: Berry, Rachel L., et al.
Publicado: (2015)

Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin
por: Martínez-Estrada, Ofelia M., et al.
Publicado: (2009)

Acute Multiple Organ Failure in Adult Mice Deleted for the Developmental Regulator Wt1
por: Chau, You-Ying, et al.
Publicado: (2011)

High-efficiency Rosa26 knock-in vector construction for Cre-regulated overexpression and RNAi
por: Hohenstein, Peter, et al.
Publicado: (2008)

Wt1, the mesothelium and the origins and heterogeneity of visceral fat progenitors
por: Chau, You-Ying, et al.
Publicado: (2015)

Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1
por: Kendall, Timothy James, et al.
Publicado: (2019)

Endothelial deletion of Wt1 disrupts coronary angiogenesis and myocardium development
por: Ramiro-Pareta, Marina, et al.
Publicado: (2023)

Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source
por: Chau, You-Ying, et al.
Publicado: (2014)

Activation of podocyte Notch mediates early Wt1 glomerulopathy
por: Asfahani, Rowan I., et al.
Publicado: (2018)

11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis
por: Davidson, Callam T., et al.
Publicado: (2023)

LINking microRNAs, kidney development, and Wilms tumors
por: Hohenstein, Peter, et al.
Publicado: (2014)

HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies
por: Tracey, Natasha, et al.
Publicado: (2019)

WT1 Is Necessary for the Proliferation and Migration of Cells of Renin Lineage Following Kidney Podocyte Depletion
por: Kaverina, Natalya V., et al.
Publicado: (2017)

Restricted differentiative capacity of Wt1-expressing peritoneal mesothelium in postnatal and adult mice
por: Wilm, Thomas P., et al.
Publicado: (2021)

The -KTS splice variant of WT1 is essential for ovarian determination in mice
por: Gregoire, Elodie P, et al.
Publicado: (2023)

Development of mouse models of angiosarcoma driven by p53
por: Salter, Donald M., et al.
Publicado: (2019)

The role of DNA methylation in ovarian cancer chemoresistance: A narrative review
por: Song, Kaiyang, et al.
Publicado: (2023)

About language : tasks for teachers of English /
por: Thornburn, Scott, 1950-
Publicado: (2017)

WT1 peptide analogue WT1-126Y enhances leukemia lysis
por: Alqudaihi, Ghofran, et al.
Publicado: (2014)

Kindlin-1 regulates IL-6 secretion and modulates the immune environment in breast cancer models
por: Webb, Emily R, et al.
Publicado: (2023)

Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia
por: Song, Huan, et al.
Publicado: (2022)

Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide
por: Oji, Yusuke, et al.
Publicado: (2016)

A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation
por: Kaneko, Y, et al.
Publicado: (2015)

A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours
por: Eskens, F A L M, et al.
Publicado: (2014)

Wilms’ Tumour gene 1 (WT1) as an immunotherapeutic target
por: Coosemans, A.
Publicado: (2011)

Loss of Integrin-Linked Kinase Sensitizes Breast Cancer to SRC Inhibitors
por: Beetham, Henry, et al.
Publicado: (2022)

Isolating $Wt$ production at the LHC
por: White, Chris D., et al.
Publicado: (2009)

WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1
por: Lv, Long, et al.
Publicado: (2015)

Fabrication and wear behaviour of Mg-3wt.%Al-x wt. % SiC composites
por: Jayasathyakawin, S., et al.
Publicado: (2023)

Diversity of Matriptase Expression Level and Function in Breast Cancer
por: Welman, Arkadiusz, et al.
Publicado: (2012)

Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment
por: Dawson, John C., et al.
Publicado: (2021)

Microstructure and Hot Deformation Behavior of the Mg–8 wt.% Sn–1.5 wt.% Al Alloy
por: Sun, Zhaoqian, et al.
Publicado: (2021)

Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
por: Uttenthal, Benjamin, et al.
Publicado: (2014)

The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
por: Nannini, Margherita, et al.
Publicado: (2017)

ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling
por: Bolado-Carrancio, Alfonso, et al.
Publicado: (2021)

Editorial: WT1 in Development and Disease
por: Chau, You-Ying, et al.
Publicado: (2022)

Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUS(WT) transgenic mice
por: So, Eva, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qaenl7erut38mgtah9b2tet4rg